Adrenal Disorders
Abstract E-Poster Presentation
Samah Abu Omar, MBBS
Internal Medicine Resident PGY2
The MedStar Health
Baltimore, Maryland, United States
Patients with pheochromocytoma present with paroxysmal headaches, palpitations, excessive sweating, and may have cardiac manifestations such as pericardial effusion and heart failure. We describe a patient with cardiac tamponade who was found to have a previously undiagnosed pheochromocytoma.
Case Description:
A 53-year-old female with hypertension and recently diagnosed stress-induced cardiomyopathy s/p STEMI presented with fever, malaise, headache, and shortness of breath for 2 days. She was found to have pneumonia and was admitted to the hospital. Chest CT scan revealed small pericardial effusion and incidental right adrenal mass 4.0 x 3.5 cm. MRI abdomen with contrast demonstrated enhancing right adrenal mass 4.1 x by 3.6 cm containing fluid indicating cystic change or necrosis. In retrospect the patient endorsed palpitations, headaches, and diaphoresis over the last 3 years. During hospitalization, she experienced tachycardia with heart rate 170 bpm, hypertension with blood pressure (BP) 160/110 mmHg, and headaches. EKG showed sinus tachycardia. Lab results revealed urinary metanephrine-to-creatinine ratio 5420 mcg/gm Cr, plasma metanephrine 13.75 nmol/L, plasma normetanephrines 0.92 nmol/L, plasma aldosterone < 3.0 ng/dL, renin 1.8 ng/mL/hr, ACTH 5.6 pg/mL and AM cortisol 38.6 mcg/dL. She was started on prazosin for BP control and diltiazem for heart rate control.
Unfortunately, the patient developed severe thrombocytopenia, altered mentation and hemodynamic instability with BP 40/20 mmHg requiring transfer to the ICU for intubation and vasopressors. Bedside ultrasound revealed cardiac tamponade, but the patient was not a candidate for surgical intervention due to severe thrombocytopenia and risk of bleeding. After a family meeting, the patient was transitioned to comfort care and died later that day.
Discussion:
Pheochromocytoma has a wide range of presentations. Up to 40% of patients are asymptomatic and present with only an adrenal incidentaloma. We report this case to raise providers’ awareness of the rare life-threatening presentation of pheochromocytoma. Providers evaluating a patient with stress-induced cardiomyopathy should consider catecholamine-induced cardiomyopathy in the setting of unrecognized pheochromocytoma. The pathophysiology includes catecholamine-associated vasoconstriction and direct toxic effect on myocardium. Therefore, clinicians should have a high index of suspicion when patients present with these symptoms because early surgical intervention can be lifesaving.